His work profoundly affects anyone who has experienced disease, which is everyone.
This latter patient experienced disease progression and was ultimately not eligible for liver transplantation.
Fourteen patients (32%) were 5-year survivors; 1 of these patients later experienced disease recurrence and died.
A total of six patients experienced disease relapse post HCT and three patients died; due to progressive disease in two and pulmonary infection in one.
After their first implant, five patients experienced disease recurrence.
In this cohort of 582 ED patients with nonsevere sepsis, 108 (18.6 %) experienced disease progression.
In the present study, almost one in five patients presenting to the ED with sepsis experienced disease progression.
Twenty-eight (23.9%) patients experienced disease relapse after HSCT and 48 (41%) graft versus host disease prior ICU admission.
Moreover, only 9 (32.1 %) patients experienced disease progression; for eight of these patients, it was identified during the observational follow-up period.
At the time of this analysis, 34 patients (37%) experienced disease relapse, and 25 (27%) of the patients died from disease progression.
The majority of patients are alive at last follow-up, and a low percentage experienced disease recurrence or death from disease.
